AR079569A1 - Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usos - Google Patents

Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usos

Info

Publication number
AR079569A1
AR079569A1 ARP100104796A ARP100104796A AR079569A1 AR 079569 A1 AR079569 A1 AR 079569A1 AR P100104796 A ARP100104796 A AR P100104796A AR P100104796 A ARP100104796 A AR P100104796A AR 079569 A1 AR079569 A1 AR 079569A1
Authority
AR
Argentina
Prior art keywords
het1
substituted simply
hal
simply
atoms
Prior art date
Application number
ARP100104796A
Other languages
English (en)
Inventor
Brian Hodous
Margarita Wucherer-Plietker
Christina Esdar
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR079569A1 publication Critical patent/AR079569A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Son inhibidores de la proliferacion celular/actividad celular y pueden ser utilizados para el tratamiento de tumores. Reivindicacion 1: Compuestos de la formula (1) en donde significan R1 Br, Het o fenilo sustituido en forma simple por CH2OH, R1' H o Hal, R2 propilo, isopropilo, fenilo mono, bi o trisustituido por Hal y/o A, piridilo pirimidilo o piridazinilo insustituido o sustituido en forma simple por F, A, OA, O u OH, R3 H, metoximetilo, metilo o etilo, R4 A o (CH2)2NA2, R5 H, NH2, NHCH3 o OCH3, R6 H o F, Het pirazolilo, que puede estar reemplazado de manera simple por Het1, A, CHA-CO-Het1, (CH2)2OH, CH2COHet1, tienilmetilo, SO2CH3, CH2OH, CH2CN, (CH2)2CONH(CH2)2NH2, (CH2)2CONH(CH2)2NHCOO-terc-butilo, CH2CH2COHet1, (CH2)2COOH, (CH2)2COOA, (CH2)2CONH2, (CH2)2CONHA, (CH2)2CONA2, C(=CH2)A, ciclopropilmetilo o (CH2)2Het1, piridilo sustituido en forma simple por Het1, pirimidinilo o piridazinilo, Het1 piperidinilo, morfolinilo, pirrolidinilo insustituido o sustituido en forma simple por OH , o piperazinilo insustituido o sustituido en forma simple por acetilo, A alquilo no ramificado o de cadena ramificada, con 1-6 átomos de C, en donde 1-5 átomos de H pueden estar reemplazados por F o cicloalquilo con 3-6 átomos de C, Hal F, CI, Br o I, así como sus sales de uso farmacéutico, tautomeros y estereoisomeros, inclusive sus mezclas en todas las proporciones.
ARP100104796A 2009-12-23 2010-12-20 Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usos AR079569A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009060174A DE102009060174A1 (de) 2009-12-23 2009-12-23 Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate

Publications (1)

Publication Number Publication Date
AR079569A1 true AR079569A1 (es) 2012-02-01

Family

ID=43531962

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104796A AR079569A1 (es) 2009-12-23 2010-12-20 Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usos

Country Status (10)

Country Link
US (1) US8575163B2 (es)
EP (1) EP2516431B1 (es)
JP (1) JP5847091B2 (es)
CN (1) CN102666538B (es)
AR (1) AR079569A1 (es)
AU (1) AU2010335628B2 (es)
CA (1) CA2785307C (es)
DE (1) DE102009060174A1 (es)
ES (1) ES2537412T3 (es)
WO (1) WO2011076316A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012058529A2 (en) 2010-10-28 2012-05-03 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
DE102010050558A1 (de) * 2010-11-05 2012-05-10 Merck Patent Gmbh 1H-Pyrrolo[2,3-b]pyridinderivate
DE102010053347A1 (de) * 2010-12-03 2012-06-06 Merck Patent Gmbh 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
WO2013049559A1 (en) * 2011-09-30 2013-04-04 Endo Pharmaceuticals Inc. Pyridine derivatives
CN107550905B (zh) * 2017-09-11 2020-07-17 浙江永宁药业股份有限公司 多取代吡咯并吡啶类化合物的药物用途及其制备方法
SG11202104404XA (en) * 2018-11-16 2021-05-28 California Inst Of Techn Erk inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
RU2403252C2 (ru) * 2004-03-30 2010-11-10 Вертекс Фармасьютикалз Инкорпорейтед Азаиндолы, полезные в качестве ингибиторов jak и других протеинкиназ
DE102007028515A1 (de) 2007-06-21 2008-12-24 Merck Patent Gmbh 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
DE102008031517A1 (de) * 2008-07-03 2010-01-07 Merck Patent Gmbh Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate

Also Published As

Publication number Publication date
ES2537412T3 (es) 2015-06-08
DE102009060174A1 (de) 2011-06-30
US20120270871A1 (en) 2012-10-25
EP2516431B1 (de) 2015-04-15
AU2010335628A1 (en) 2012-08-09
WO2011076316A1 (de) 2011-06-30
JP5847091B2 (ja) 2016-01-20
JP2013515685A (ja) 2013-05-09
CN102666538B (zh) 2015-11-25
AU2010335628B2 (en) 2016-03-03
EP2516431A1 (de) 2012-10-31
CN102666538A (zh) 2012-09-12
US8575163B2 (en) 2013-11-05
CA2785307C (en) 2017-10-31
CA2785307A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
AR079569A1 (es) Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usos
AR122902A2 (es) Compuestos terapéuticamente activos y sus métodos de preparación
CR11738A (es) Compuestos de pirimidinona pirrolo 3-metil-2-imino fenil sustituidos como inhibidores bace-1, composiciones y su uso
NZ629432A (en) Heterocyclyl compounds as mek inhibitors
PE20151601A1 (es) Compuestos novedosos de pirimidina y piridina y su uso
CO2018002829A2 (es) Derivados de 8-[6-[3-(amino)propoxi]-3-piridil]1-isopropilimidazo[4,5-c]quinolin-2-ona como moduladores selectivos de la cinasa de la ataxia telangiectasia mutada (atm)
BR112012029647A2 (pt) novos derivados de pirimidinas
BR112014005226A2 (pt) derivados de benzonitrila como inibidores de cinase
EA201400338A1 (ru) Производные аминопиримидина для применения в качестве модуляторов киназной активности
CR20160523A (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
AR053569A1 (es) Derivados de pirazol
DOP2012000153A (es) Derivados de sulfonamida como agentes inductores de apoptosis con selectividad por bcl-2 para el tratamiento de cancer y enfermedades inmunes
DOP2014000055A (es) Derivados de pirrolopirimidina y purina
AR095347A1 (es) Compuestos orgánicos
CR11757A (es) Compuestos de triazina como inhibidores mtor y quinasa pi3
BR112015023412A2 (pt) 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante
SG194675A1 (en) Derivatives of n- [(1h-pyrazol-1-yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
AR077975A1 (es) Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
TN2012000608A1 (en) Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
RS54339B1 (en) NEW ANTIMALARIAN AGENTS
BR112014014909A2 (pt) agonistas de tgr5 não sistêmicos
TR201908392T4 (tr) (6S,9aS)-N-benzil-6-((4-hidroksifenil)metil)-4,7-diokso-8-((6-(3-(piperazin-1-il)azetidin-1-il)piridin-2-il)metil)-2-(prop-2-en-1-il)-oktahidro-1h-pirazino(2,1-c)(1,2,4)triazin-1-karboksamid bileşiği.
AR093512A1 (es) Derivados heterociclicos como moduladores de la actividad de cinasas
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
AR097277A1 (es) Derivados de urea de piperidinas

Legal Events

Date Code Title Description
FB Suspension of granting procedure